Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

TTOO | T2 Biosystems Inc

Healthcare | Diagnostics & Research | USA | NASD

Index	-	P/E	-	EPS (ttm)	-5.75	Insider Own	6.59%	Shs Outstand	333.58M	Perf Week	-13.03%
Market Cap	73.69M	Forward P/E	-	EPS next Y	-0.52	Insider Trans	-68.74%	Shs Float	311.60M	Perf Month	-31.82%
Income	-52.43M	PEG	-	EPS next Q	-0.17	Inst Own	2.09%	Short Float / Ratio	7.61% / 0.20	Perf Quarter	212.89%
Sales	13.20M	P/S	5.58	EPS this Y	92.27%	Inst Trans	0.43%	Short Interest	23.71M	Perf Half Y	-51.98%
Book/sh	-0.15	P/B	-	EPS next Y	45.12%	ROA	-135.79%	Target Price	0.15	Perf Year	-95.91%
Cash/sh	0.05	P/C	4.58	EPS next 5Y	-	ROE	-	52W Range	0.05 - 5.72	Perf YTD	-84.44%
Dividend	-	P/FCF	-	EPS past 5Y	33.92%	ROI	-	52W High	-96.14%	Beta	0.39
Dividend %	-	Quick Ratio	0.30	Sales past 5Y	51.24%	Gross Margin	-42.53%	52W Low	309.07%	ATR	0.07
Employees	158	Current Ratio	0.36	Sales Q/Q	-66.77%	Oper. Margin	-389.12%	RSI (14)	44.35	Volatility	20.97% 19.79%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	98.46%	Profit Margin	-397.14%	Rel Volume	0.93	Prev Close	0.18
Shortable	Yes	LT Debt/Eq	-	Earnings	Aug 07 AMC	Payout	-	Avg Volume	116.44M	Price	0.22
Recom	3.00	SMA20	-23.20%	SMA50	-25.96%	SMA200	-61.89%	Volume	107,923,883	Change	23.89%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-27-21	Downgrade	Alliance Global Partners	Buy → Neutral	$2.60 → $2.40
Oct-08-20	Initiated	BTIG Research	Buy	$2.50
Nov-26-19	Downgrade	Janney	Buy → Neutral
Aug-01-19	Downgrade	Alliance Global Partners	Buy → Neutral
Jul-31-19	Downgrade	Janney	Buy → Neutral
Jul-31-19	Downgrade	H.C. Wainwright	Buy → Neutral
May-16-19	Initiated	Alliance Global Partners	Buy	$5
Mar-08-19	Reiterated	H.C. Wainwright	Buy	$14 → $11
Jun-01-18	Upgrade	Leerink Partners	Mkt Perform → Outperform
May-30-18	Reiterated	H.C. Wainwright	Buy	$8.50 → $14
May-29-18	Reiterated	WBB Securities	Strong Buy	$12 → $20
Mar-29-18	Reiterated	H.C. Wainwright	Buy	$8 → $8.50
Jan-29-18	Initiated	Goldman	Neutral	$5.20
Oct-18-17	Initiated	H.C. Wainwright	Buy	$8
Mar-15-17	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Nov-10-16	Resumed	Leerink Partners	Mkt Perform	$5
Nov-02-16	Reiterated	Cantor Fitzgerald	Buy	$10 → $9
Jul-20-16	Upgrade	WBB Securities	Buy → Strong Buy	$11 → $12
Jun-22-16	Upgrade	WBB Securities	Speculative Buy → Buy	$11
Apr-12-16	Reiterated	Canaccord Genuity	Buy	$13 → $12

Show Previous Ratings

Sep-19-23 09:00AM	T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel (GlobeNewswire) -26.13%
Sep-15-23 04:05PM	T2 Biosystems Reports Granting of Inducement Award (GlobeNewswire) +6.08%
Sep-11-23 03:52PM	The Fun Is Over for TTOO Stock At Least for Now (InvestorPlace) -14.11%
Sep-07-23 04:05PM	T2 Biosystems to Participate in the Gilmartin Group Emerging Growth Company Showcase (GlobeNewswire) +13.92%
Aug-28-23 08:30AM	T2 Biosystems Praises CDCs Actions Aimed at Optimizing U.S. Hospital Sepsis Programs (GlobeNewswire) -8.84%
12:35PM	Loading…
Aug-24-23 12:35PM	Is T2 Biosystems a Hidden Gem or a Value Trap? An In-Depth Analysis (GuruFocus.com) -26.35%
Aug-15-23 10:20AM	Sidoti Events, LLCs Virtual August Micro-Cap Conference (ACCESSWIRE) +51.56%
Aug-14-23 12:38PM	4 Meme Stocks to Sell Before They Die (InvestorPlace) +15.42%
Aug-10-23 11:11AM	T2 Biosystems (TTOO) Stock Is Becoming the Next Mullen (InvestorPlace)
Aug-09-23 06:10PM	3 Meme Stocks to Sell in August Before They Crash and Burn (InvestorPlace) +10.48%
08:30AM	T2 Biosystems Regains Compliance with Nasdaqs Market Value of Listed Securities Requirement (GlobeNewswire)
08:00AM	Is TTOO Stock Really Worth $5? Or Just 5 Cents? (InvestorPlace)
06:32AM	T2 Biosystems, Inc. (NASDAQ:TTOO) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-08-23 07:42AM	Q2 2023 T2 Biosystems Inc Earnings Call (Thomson Reuters StreetEvents) +26.69%
Aug-07-23 04:22PM	T2 Biosystems: Q2 Earnings Snapshot (AP Finance)
04:05PM	Loading…
04:05PM	T2 Biosystems Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-31-23 09:29PM	GSA Capital Partners LLP Acquires Stake in T2 Biosystems Inc (GuruFocus.com) +27.16%
08:30AM	T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirements (GlobeNewswire)
Jul-28-23 08:30AM	T2 Biosystems to Attend Upcoming Investor Conferences (GlobeNewswire)
Jul-24-23 04:05PM	T2 Biosystems to Report Second Quarter 2023 Financial Results on August 7, 2023 (GlobeNewswire) -6.36%
Jul-21-23 04:05PM	T2 Biosystems Reports Granting of Inducement Award (GlobeNewswire)
Jul-20-23 08:30AM	T2 Biosystems Receives FDA Breakthrough Device Designation for Candida Auris Diagnostic Test (GlobeNewswire)
Jul-12-23 03:59PM	7 Doomed Stocks Destined for Disaster (InvestorPlace) -15.74%
08:30AM	T2 Biosystems Announces Preliminary Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-06-23 08:00AM	T2 Biosystems Announces Conversion of Approximately Twenty Percent of CRG Term Loan into Equity (GlobeNewswire) +12.16%
Jun-09-23 09:15AM	T2 Biosystems Announces Clinical Collaboration with Vanderbilt University Medical Center to Implement and Evaluate the T2Bacteria Panel for Clinical Use (GlobeNewswire) -14.42%
Jun-05-23 09:00AM	T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for Candida Auris Diagnostic Test (GlobeNewswire) -31.37%
May-30-23 09:00AM	T2 Biosystems Announces Second Largest Sepsis-Driven Instrument Sale in Company History (GlobeNewswire) +42.39%
May-23-23 11:12PM	Q1 2023 T2 Biosystems Inc Earnings Call (Thomson Reuters StreetEvents) -38.51%
08:50AM	T2 Biosystems: Q1 Earnings Snapshot (AP Finance)
08:05AM	Loading…
08:05AM	T2 Biosystems Announces First Quarter 2023 Financial Results (GlobeNewswire)
08:01AM	T2 Biosystems Announces Exploration of Strategic Alternatives and the Implementation of a Restructuring Program (GlobeNewswire)
08:00AM	T2 Biosystems Announces FDA 510(k) Submission for the T2Biothreat Panel (GlobeNewswire)
May-22-23 08:15AM	T2 Biosystems Reschedules First Quarter 2023 Financial Results Reporting to May 23, 2023 (GlobeNewswire)
May-19-23 09:22AM	WBB Research Institute Webcast Highlighted the Need For a Global Response to Candida auris and Other Deadly Antimicrobial Resistant Pathogens (Newsfile)
May-17-23 04:05PM	T2 Biosystems Reschedules First Quarter 2023 Financial Results Reporting to May 22, 2023 (GlobeNewswire)
May-15-23 04:05PM	T2 Biosystems Postpones Reporting of First Quarter 2023 Financial Results (GlobeNewswire)
May-01-23 04:05PM	T2 Biosystems to Report First Quarter 2023 Financial Results on May 15, 2023 (GlobeNewswire) -6.36%
Apr-26-23 08:30AM	T2 Biosystems Highlights New Clinical Data Presented at the ECCMID 2023 Conference (GlobeNewswire)
Apr-19-23 03:39PM	T2 Biosystems, Inc.'s (NASDAQ:TTOO) Low P/S No Reason For Excitement (Simply Wall St.)
Apr-05-23 08:00AM	T2 Biosystems Announces Webinar and White Paper Highlighting T2Candida Panel Clinical Data and Best Practices (GlobeNewswire)
Mar-23-23 09:00AM	T2 Biosystems Affirms Plans to Add Candida Auris Detection to the FDA-Cleared T2Candida Panel (GlobeNewswire) -7.97%
Mar-14-23 11:12AM	T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2022 Earnings Call Transcript (Insider Monkey)
07:24AM	Q4 2022 T2 Biosystems Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-13-23 04:05PM	T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-03-23 08:00AM	T2 Biosystems to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023 (GlobeNewswire)
Feb-15-23 07:30AM	T2 Biosystems Announces Pricing of $12 Million Public Offering (GlobeNewswire) -23.19%
Feb-14-23 05:29AM	T2 Biosystems Touts Positive Results From T2Biothreat Panel Study (Benzinga) -22.86%
Feb-13-23 04:19PM	T2 Biosystems Announces Proposed Public Offering (GlobeNewswire)
04:01PM	T2 Biosystems Announces Positive Results upon Completion of U.S. Clinical Evaluation for the T2Biothreat Panel (GlobeNewswire)
01:59PM	The 7 Best Stocks to Short This Week (InvestorPlace)
Feb-06-23 04:05PM	T2 Biosystems Advances to the Phase 2 in HHS and the Steven and Alexandra Cohen Foundations LymeX Diagnostics Prize (GlobeNewswire) +5.71%
Feb-03-23 04:30PM	T2 Biosystems Reports Granting of Inducement Award (GlobeNewswire)
Jan-23-23 04:30PM	T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Dec-28-22 09:00AM	T2 Biosystems Announces Extension of Multiyear Innovative Technology Contract with Vizient, Inc. (GlobeNewswire) +7.55%
Dec-08-22 08:28AM	T2 Biosystems Highlights Peer-Reviewed Article Linking COVID-19 and Sepsis and Underscoring CDC Call for Adoption of Early and Accurate Microbial Diagnosis to Guide Targeted Initial Antimicrobial Therapy (GlobeNewswire)
Nov-16-22 05:08AM	T2 Biosystems Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-10-22 04:05PM	T2 Biosystems Announces Third Quarter 2022 Financial Results (GlobeNewswire) +5.11%
04:04PM	T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement (GlobeNewswire)
Nov-09-22 04:05PM	T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-07-22 08:30AM	HHS and the Cohen Foundation Name T2 Biosystems a Phase 1 Winner in LymeX Diagnostics Prize (GlobeNewswire)
Nov-01-22 08:30AM	T2 Biosystems Regains Compliance with Nasdaqs Minimum Bid Price Rule (GlobeNewswire)
Oct-31-22 05:57PM	T2 Biosystems to Report Third Quarter 2022 Financial Results on November 10, 2022 (GlobeNewswire)
Oct-20-22 09:05AM	T2 Biosystems Initiates Studies to Add Acinetobacter Baumannii to the FDA-Cleared T2Bacteria Panel (GlobeNewswire)
Oct-14-22 08:30AM	T2 Biosystems Highlights Multiple New Studies Demonstrating Improved Rapid Detection Across Several Patient Populations (GlobeNewswire) -9.02%
Oct-13-22 09:00AM	T2 Biosystems Announces Plan to Commercialize a Diagnostic Test for Early Lyme Disease (GlobeNewswire) -8.93%
Oct-12-22 10:59AM	Amid Plunging COVID-19 Test Sales T2 Biosystems Cuts Annual Guidance, Shares Fall (Benzinga) -30.00%
08:35AM	T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook (GlobeNewswire)
08:30AM	T2 Biosystems Announces Reverse Stock Split Effective Today (GlobeNewswire)
Sep-29-22 08:30AM	T2 Biosystems Announces BARDA Exercise of Contract Option 3 Valued at $3.7 Million (GlobeNewswire)
Sep-23-22 07:50AM	T2 Biosystems Stock Jumps On Distribution Pact In Baltic Countries (Benzinga) +18.57%
Sep-22-22 04:05PM	T2 Biosystems Announces Commercial Expansion Through Distributor in Baltic Region (GlobeNewswire) -11.83%
Sep-08-22 04:05PM	T2 Biosystems to Participate in the H.C. Wainwright Global Investment Conference (GlobeNewswire) +8.65%
Aug-18-22 04:05PM	T2 Biosystems to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase (GlobeNewswire)
Aug-16-22 08:30AM	T2 Biosystems Q2 Sales Below Expectations, Sticks To Annual Guidance (Benzinga) -21.05%
Aug-15-22 04:05PM	T2 Biosystems Announces Second Quarter 2022 Financial Results (GlobeNewswire) +6.43%
Aug-09-22 08:30AM	T2 Biosystems to Explore Potential to Develop Rapid Molecular Diagnostic Test for Monkeypox Virus (GlobeNewswire) -6.85%
Aug-05-22 04:43PM	What to watch: Earnings and economic data due out next week (Yahoo Finance Video)
Jul-29-22 04:05PM	T2 Biosystems Reports Granting of Inducement Awards (GlobeNewswire)
Jul-28-22 04:32PM	T2 Biosystems to Report Second Quarter 2022 Financial Results on August 15, 2022 (GlobeNewswire) -8.71%
Jul-27-22 04:05PM	T2 Biosystems to Participate in the Canaccord Genuity Annual Growth Conference (GlobeNewswire)
Jul-11-22 08:00AM	T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme Panel (GlobeNewswire)
Jul-06-22 10:21AM	T2 Biosystems Shares Slide As Interim Q2 Sales Trail Consensus (Benzinga) -15.87%
08:30AM	T2 Biosystems Announces Preliminary Second Quarter 2022 Financial Results (GlobeNewswire)
Jun-15-22 04:05PM	T2 Biosystems to Appear on the Benzinga All Access Show on June 17, 2022 (GlobeNewswire) +13.18%
Jun-10-22 09:00AM	T2 Biosystems Receives Nasdaq Extension to Comply with Bid Price Rule; Company to Transfer to Nasdaq Capital Market (GlobeNewswire)
May-20-22 09:17AM	T2 Biosystems Announces Issuance of U.S. Patent for Direct Detection of Lyme Disease (GlobeNewswire)
May-05-22 04:05PM	T2 Biosystems Announces First Quarter 2022 Financial Results (GlobeNewswire)
04:02PM	T2 Biosystems Announces Receipt of Nasdaq Delisting Notice (GlobeNewswire)
Apr-28-22 08:30AM	T2 Biosystems Announces Formation and Members of Scientific Advisory Board (GlobeNewswire)
Apr-27-22 08:30AM	T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel (GlobeNewswire)
Apr-21-22 04:05PM	T2 Biosystems to Report First Quarter 2022 Financial Results on May 5, 2022 (GlobeNewswire) -9.95%
Apr-14-22 04:05PM	T2 Biosystems Reports Granting of Inducement Award (GlobeNewswire)
Mar-31-22 04:57PM	T2 Biosystems Announces BARDA Exercise of Contract Option 2B Valued at $4.4 Million (GlobeNewswire) +9.81%
Mar-29-22 08:00AM	T2 Biosystems to Host Analyst and Investor Day on April 12, 2022 (GlobeNewswire) +8.72%
Feb-17-22 04:05PM	T2 Biosystems Announces Fourth Quarter & Full Year 2021 Financial Results (GlobeNewswire) -12.99%
Feb-16-22 09:00AM	T2 Biosystems Announces Commercial Expansion Through Distributors in Norway, Finland and Türkiye (GlobeNewswire)
Feb-15-22 09:27AM	T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement (GlobeNewswire) +16.75%
Feb-08-22 04:05PM	T2 Biosystems to Report Fourth Quarter and Full Year 2021 Financial Results on February 17, 2022 (GlobeNewswire)
Feb-04-22 04:05PM	T2 Biosystems Reports Granting of Inducement Award (GlobeNewswire)

T2 Biosystems, Inc. engages in the development of a proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables detection of pathogens, biomarkers, and other abnormalities in a range of unpurified patient sample types. The firm's products include the T2Dx Instrument, the T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CR Group L.P.	10% Owner	Sep 28	Sale	0.16	7,148,945	1,125,959	0	Sep 29 04:30 PM
CR Group L.P.	10% Owner	Sep 27	Sale	0.19	5,981,202	1,145,998	571,796	Sep 29 04:30 PM
CR Group L.P.	10% Owner	Sep 26	Sale	0.20	5,392,920	1,082,359	1,050,192	Sep 28 04:30 PM
CR Group L.P.	10% Owner	Sep 25	Sale	0.25	250,000	62,500	1,481,535	Sep 27 05:53 PM
CR Group L.P.	10% Owner	Sep 22	Sale	0.26	5,079,344	1,314,534	1,501,531	Sep 26 05:15 PM
CR Group L.P.	10% Owner	Sep 21	Sale	0.30	6,338,211	1,904,632	1,907,794	Sep 25 08:30 PM
CR Group L.P.	10% Owner	Sep 20	Sale	0.31	7,753,710	2,408,302	2,414,745	Sep 22 04:15 PM
CR Group L.P.	10% Owner	Sep 19	Sale	0.37	10,401,466	3,806,937	3,034,912	Sep 21 04:30 PM
Gibbs Michael Terrence	General Counsel	Mar 28	Sale	0.48	239	115	6,612	Apr 06 01:08 PM
Sperzel John J III	Chairman and CEO	Feb 28	Sale	0.59	2,898	1,710	17,329	Mar 09 04:00 PM
Gibbs Michael Terrence	General Counsel	Feb 28	Sale	0.59	1,585	935	6,517	Mar 09 04:00 PM
Sprague John M	Chief Financial Officer	Feb 28	Sale	0.59	1,148	677	7,268	Mar 09 04:00 PM
Sperzel John J III	Chairman and CEO	Feb 22	Sale	0.65	6,875	4,469	13,560	Mar 09 04:00 PM
Gibbs Michael Terrence	General Counsel	Feb 22	Sale	0.65	2,145	1,394	5,188	Mar 09 04:00 PM
Sprague John M	Chief Financial Officer	Feb 22	Sale	0.65	1,545	1,004	5,502	Mar 09 04:00 PM
Giffin Brett A.	Chief Commercial Officer	Feb 22	Sale	0.65	537	349	841	Mar 09 04:00 PM
Giffin Brett A.	Chief Commercial Officer	Nov 10	Sale	1.79	1,292	2,317	2,253	Nov 22 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TTOO | T2 Biosystems Inc

Upgrade your FINVIZ experience